Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1990-6-21
pubmed:abstractText
Human immunodeficiency virus (HIV) vaccines targeted at blocking HIV-CD4 interactions are expected to be less affected by the sequence heterogeneity of HIV than those targeted at variable regions of the envelope outercoat glycoprotein, gp120. All potential CD4 binding sites identified thus far in HIV are localized in the C-terminal region of gp120. In this study we demonstrate that the N-terminal region of gp120 also contains conserved residues critical for binding to CD4 and that gp120-CD4 interactions can be blocked by an antiserum with binding specificity to an N-terminal region of gp120. These results suggest that not all potential CD4 binding sites are present in the C-terminal region of gp120 and that an alternative HIV vaccine development strategy may have to include the N-terminal gp120 region as a component to raise effective CD4-blocking antibodies.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2410792, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2423250, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2424612, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2441877, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2458487, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2460639, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2474670, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2475780, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2550679, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2578615, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2704072, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2829181, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2842694, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-2842778, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-3001934, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-3014529, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-3014647, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-3018753, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-3088563, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-3094962, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-3346572, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-3500514, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-3629244, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-3881765, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-6083454, http://linkedlifedata.com/resource/pubmed/commentcorrection/2339113-6096719
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3695-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
The N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4.
pubmed:affiliation
Department of Cancer Biology, Harvard University School of Public Health, Boston, MA 02115.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.